DE68917556T2 - Quinolyloxazol-2-one, nützlich als Proteinkinase-C-Inhibitoren. - Google Patents

Quinolyloxazol-2-one, nützlich als Proteinkinase-C-Inhibitoren.

Info

Publication number
DE68917556T2
DE68917556T2 DE68917556T DE68917556T DE68917556T2 DE 68917556 T2 DE68917556 T2 DE 68917556T2 DE 68917556 T DE68917556 T DE 68917556T DE 68917556 T DE68917556 T DE 68917556T DE 68917556 T2 DE68917556 T2 DE 68917556T2
Authority
DE
Germany
Prior art keywords
quinolyloxazol
inhibitors
useful
protein kinase
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68917556T
Other languages
English (en)
Other versions
DE68917556D1 (de
Inventor
Winton Dr Jones
George P Claxton
Phillip J Robinson
Richard C Dage
Hsien C Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE68917556D1 publication Critical patent/DE68917556D1/de
Application granted granted Critical
Publication of DE68917556T2 publication Critical patent/DE68917556T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
DE68917556T 1988-10-24 1989-09-28 Quinolyloxazol-2-one, nützlich als Proteinkinase-C-Inhibitoren. Expired - Fee Related DE68917556T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/261,435 US4886811A (en) 1988-10-24 1988-10-24 Qunolyloxazole-2-ones useful as proteinkinase C inhibitors

Publications (2)

Publication Number Publication Date
DE68917556D1 DE68917556D1 (de) 1994-09-22
DE68917556T2 true DE68917556T2 (de) 1994-12-15

Family

ID=22993289

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917556T Expired - Fee Related DE68917556T2 (de) 1988-10-24 1989-09-28 Quinolyloxazol-2-one, nützlich als Proteinkinase-C-Inhibitoren.

Country Status (21)

Country Link
US (1) US4886811A (de)
EP (1) EP0365863B1 (de)
JP (2) JP2879454B2 (de)
KR (1) KR0162637B1 (de)
CN (1) CN1025854C (de)
AR (1) AR246733A1 (de)
AT (1) ATE110074T1 (de)
AU (1) AU613302B2 (de)
CA (1) CA2000804C (de)
DE (1) DE68917556T2 (de)
DK (1) DK461389A (de)
ES (1) ES2061863T3 (de)
FI (1) FI93112C (de)
HU (1) HUT58088A (de)
IE (1) IE893011L (de)
IL (1) IL91788A (de)
NO (1) NO894210L (de)
NZ (1) NZ230718A (de)
PH (1) PH27450A (de)
PT (1) PT91870B (de)
ZA (1) ZA897259B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036093A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
DE3907414A1 (de) * 1989-03-08 1990-09-13 Hoechst Ag Die anwendung inhalierter schleifendiuretika zur behandlung von allergen-induzierten nasalen reaktionen
ZA908936B (en) * 1989-11-13 1991-09-25 Merrell Dow Pharma Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones
US5190957A (en) * 1989-11-13 1993-03-02 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones
PH27309A (en) * 1989-11-13 1993-05-28 Merrell Dow Pharma Prevention of glycoprotein enveloped virus infectivity by quinolyl-and isoquinolyloxazone-2-ones
US5182293A (en) * 1989-11-13 1993-01-26 Merrell Dow Pharmaceuticals Inc. Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
WO1994026303A1 (en) * 1993-05-13 1994-11-24 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
GB9929216D0 (en) * 1999-12-11 2000-02-02 Univ Bristol Isoquinoline and Quinoline Containing substances
WO2006130090A1 (en) * 2005-06-03 2006-12-07 Pronas Pharma Ab Use of a substance which inhibits endothelin type b and 5-hydroxytryptamine type 1b receptor upregulation in the treatment of ischemic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025215A (en) * 1959-07-29 1962-03-13 Monsanto Chemicals Bis (8-quinolyl carbonate) derivatives
US3857877A (en) * 1973-01-12 1974-12-31 Karamchand Premchand Private 8-hydroxy quinoline derivatives
US4565820A (en) * 1980-07-28 1986-01-21 Pfizer Inc. Hypoglycemic 5-pyrrolyl, indolyl and quinolyl substituted oxazolidine-2,4-diones and their use
GB8505492D0 (en) * 1985-03-04 1985-04-03 Roussel Lab Ltd Chemical compounds
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4670450A (en) * 1985-11-13 1987-06-02 Merrell Dow Pharmaceuticals Inc. Cardiotonic thiazolones
US4728661A (en) * 1985-11-13 1988-03-01 Merrell Dow Pharmaceuticals Inc. Cardiotonic phenyl oxazolones
US4698353A (en) * 1985-11-13 1987-10-06 Merrell Dow Pharmaceuticals Inc. Cardiotonic heterocyclic oxazolones
US4681940A (en) * 1985-11-19 1987-07-21 American Home Products Corporation 5-[3-[[2-quinolyl]methoxy]phenyl]-1,3-oxazoles

Also Published As

Publication number Publication date
PH27450A (en) 1993-07-02
EP0365863A3 (en) 1990-11-07
FI894459A (fi) 1990-04-25
JPH11152285A (ja) 1999-06-08
ATE110074T1 (de) 1994-09-15
CN1042145A (zh) 1990-05-16
NO894210D0 (no) 1989-10-23
JPH02164878A (ja) 1990-06-25
FI894459A0 (fi) 1989-09-20
JP2983970B2 (ja) 1999-11-29
FI93112C (fi) 1995-02-27
AU613302B2 (en) 1991-07-25
ES2061863T3 (es) 1994-12-16
KR0162637B1 (ko) 1998-12-01
KR900006307A (ko) 1990-05-07
DE68917556D1 (de) 1994-09-22
AR246733A1 (es) 1994-09-30
IL91788A (en) 1994-04-12
HUT58088A (en) 1992-01-28
EP0365863A2 (de) 1990-05-02
NZ230718A (en) 1990-11-27
US4886811A (en) 1989-12-12
JP2879454B2 (ja) 1999-04-05
CA2000804A1 (en) 1990-04-24
NO894210L (no) 1990-04-25
IE893011L (en) 1990-04-24
ZA897259B (en) 1990-07-25
FI93112B (fi) 1994-11-15
DK461389A (da) 1990-04-25
HU895410D0 (en) 1990-01-28
DK461389D0 (da) 1989-09-19
IL91788A0 (en) 1990-06-10
PT91870B (pt) 1995-05-31
AU4249389A (en) 1990-04-26
CN1025854C (zh) 1994-09-07
EP0365863B1 (de) 1994-08-17
CA2000804C (en) 1999-04-06
PT91870A (pt) 1990-04-30

Similar Documents

Publication Publication Date Title
FI893167A (fi) Moerk, neutralgrao, nickelfri glaskomposition.
FI895157A0 (fi) Laosanordning foer flyttbara anordningars, saerskilt sjukvaeddars, hjul.
NO900543D0 (no) Fremgangsmaate for retningsbestemmelse i borehull.
FI892117A0 (fi) Enskiktigt, soemmat pappersmaskintyg.
DE68922366T2 (de) Piperidinyl-Benzimidazole als Antihistaminica.
FI902898A0 (fi) Lutningskompensator foer snabbgaoende fordon, saerskilt raelsfordon.
DE68917556T2 (de) Quinolyloxazol-2-one, nützlich als Proteinkinase-C-Inhibitoren.
FI894892A0 (fi) Koppling foer fluidledningar, speciellt snabbkoppling.
FI893756A0 (fi) Slaett, keramiskt foerbindningselement.
FI896346A0 (fi) Organiska, svavelhaltiga foereningar foer anvaendning i positiva, elektrostatiska, vaetskeformiga framkallningsmedel.
FI896345A0 (fi) Bipolaert, vaetskeformigt, elektrostatiskt framkallningsmedel.
NO892948L (no) Modifiserte proteiner.
FI903792A0 (fi) Nickel-kopparskaerstenkonverter, i vilken anvaends kvaeveanrikad blaestring.
FI892163A0 (fi) Valsanordning, saerskilt kalander.
FI895500A0 (fi) Ledning, inklusive drivanordning foer pappers- eller kartongbanor.
IT8919815A0 (it) Compasso, particolarmente per disegnatori.
NO892244L (no) Fremgangsmaate til immundiagnostisk bestemmelse.
FI892822A0 (fi) Ljuskaensliga, negativt arbetande offsettryckplattor.
NO884559L (no) Taueoeye for slepewire.
FI884176A0 (fi) Foerbaettringar i spickbleck, spikblecksfoerband och- konstruktioner.
FI882802A (fi) Vaograet portenhet foer burar, saosom hoensburar.
FI880390A (fi) Flaekt, saerskilt en centrifugalflaekt.
NO911826L (no) 14alfa,17alfa-etano-oestratriener.
NO913672D0 (no) 14alfa,17delta-etano-oestratriener.
FI912463A0 (fi) Synnerligen basiskt, fosfatloest, flytande tvaettmedel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee